Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.63%

Hemispherx Biopharma, Inc. (HEB)

-NYSE MKT
0.18 Up 0.02(9.94%) Aug 31, 4:00PM EDT
Add to Portfolio
Prev Close:0.16
Open:0.18
Bid:0.13 x 3000
Ask:0.19 x 1100
1y Target Est:1.45
Beta:-0.360345
Earnings Date:Nov 9 - Nov 13 (Est.)
Day's Range:0.17 - 0.18
52wk Range:0.14 - 0.40
Volume:347,441
Avg Vol (3m):731,852
Market Cap:43.70M
P/E (ttm):N/A
EPS (ttm):-0.08
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
HEBUp 9.94%43.70M
GILDDown 2.51%154.20B
MRKDown 2.75%151.68B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):236.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Dec-14) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the Un... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback